1. Home
  2. XFOR vs NEGG Comparison

XFOR vs NEGG Comparison

Compare XFOR & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XFOR
  • NEGG
  • Stock Information
  • Founded
  • XFOR 2014
  • NEGG 2001
  • Country
  • XFOR United States
  • NEGG United States
  • Employees
  • XFOR N/A
  • NEGG N/A
  • Industry
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • NEGG Other Specialty Stores
  • Sector
  • XFOR Health Care
  • NEGG Consumer Discretionary
  • Exchange
  • XFOR Nasdaq
  • NEGG Nasdaq
  • Market Cap
  • XFOR 118.4M
  • NEGG 122.3M
  • IPO Year
  • XFOR N/A
  • NEGG 2010
  • Fundamental
  • Price
  • XFOR $2.68
  • NEGG $11.38
  • Analyst Decision
  • XFOR Strong Buy
  • NEGG
  • Analyst Count
  • XFOR 3
  • NEGG 0
  • Target Price
  • XFOR $72.33
  • NEGG N/A
  • AVG Volume (30 Days)
  • XFOR 357.1K
  • NEGG 1.1M
  • Earning Date
  • XFOR 08-07-2025
  • NEGG 04-28-2025
  • Dividend Yield
  • XFOR N/A
  • NEGG N/A
  • EPS Growth
  • XFOR N/A
  • NEGG N/A
  • EPS
  • XFOR 2.16
  • NEGG N/A
  • Revenue
  • XFOR $31,364,000.00
  • NEGG $1,235,576,000.00
  • Revenue This Year
  • XFOR $1,106.53
  • NEGG N/A
  • Revenue Next Year
  • XFOR N/A
  • NEGG N/A
  • P/E Ratio
  • XFOR $1.23
  • NEGG N/A
  • Revenue Growth
  • XFOR N/A
  • NEGG N/A
  • 52 Week Low
  • XFOR $2.62
  • NEGG $3.32
  • 52 Week High
  • XFOR $31.20
  • NEGG $26.40
  • Technical
  • Relative Strength Index (RSI)
  • XFOR 36.75
  • NEGG 62.60
  • Support Level
  • XFOR $2.62
  • NEGG $8.95
  • Resistance Level
  • XFOR $2.98
  • NEGG $12.75
  • Average True Range (ATR)
  • XFOR 0.38
  • NEGG 2.28
  • MACD
  • XFOR -0.02
  • NEGG 0.15
  • Stochastic Oscillator
  • XFOR 9.68
  • NEGG 51.86

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.

Share on Social Networks: